4[4]Kislinger T,Fu C,Huber B,et al.N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression[J].J Biol Chem,1999,274(44):31740-31749.
5[5]Beisswenger PJ,Makita Z,Curphey TJ,et al.Formation of immunochemical advanced glycosylation end-products precedes and correlates with early manifestations of renal and retinal disease in diabetes[J].Diabetes,1995,44(7):824-829.
6[6]Doi T,Vlassara H,Kirstein M,et al.Receptor-specific increase in extracelluar matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platederived growth factor[J].Proc Natl Acad Sci USA,1992,89(7):2873.
7[7]Oldfield MD,Bach LA,Forbes JM,et al.Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)[J].J Clin Invest,2001,108(12):1853-1863.
8[8]greene DA,Lattimer SA,Sima AA,et al.Sorbitol phosphoinositides and sodiumpotassium ATP-ase in the pathogenesis of diabetic complications[J].N Engl J Med,1987,316(10):559-606.
9[9]Cohen MP,Klepser H.Glomerular Na+,K+-ATP ase activity in acute and chronic diabetes and with aldose reductase inhibition[J].Diabetes,1988,37(5):558-562.
10[10]Lee TS,MacGregor LC,Fluharty SJ.Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells[J].J Clin invest,1989,83(1):90-94.
